New Anticancer Drugs from Cultured and Collected Marine Organisms

Autor:	Stephanie Mayhead, Robert A. Kramer, Russell Peterson, Katherine Drainville, Lyndon M. West, Bo Li, Paul R. Jensen, Craig R. Fairchild, Robert A. Wild, Wendy K. Strangman, Michael T. Davies-Coleman, Gregory D. Vite, D. J. Faulkner, Yuzuru Shimizu, M. Rao, William Fenical, Catherine Sincich, William C. Rose, Christopher A. Kauffman, Sudhakararao Thammana, Eric Kantorowski
Rok vydání:	2003
Předmět:	Pharmacology Drug discovery business.industry Pharmaceutical Science General Medicine Biology Biotechnology Marine bacteriophage Complementary and alternative medicine Drug Discovery Molecular Medicine Developmental Therapeutics Pharmaceutical sciences business
Zdroj:	Pharmaceutical Biology. 41:6-14
ISSN:	1744-5116 1388-0209
DOI:	10.1080/1388020039051741
Popis:	This paper provides an outline of a collaborative research project between researchers at the University of California, San Diego, University of Rhode Island, and the Bristol-Myers Squibb Pharmaceutical Research Institute, with participating members from the Developmental Therapeutics Branch of the National Cancer Institute. The program, formally funded by the National Cancer Institute under the National Cooperative Drug Discovery Groups (NCDDG) program, seeks to discover new anticancer drugs from marine organisms, in particular invertebrates such as sponges and ascidians, and marine microalgae, marine bacteria and fungi. In this report, the program and results obtained since its beginning in 2000 will be summarized.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6ba196168b70c07d4c358277f2db09ac https://doi.org/10.1080/1388020039051741 Zobrazit plný text záznamu Plný text ve formátu PDF